Benitec Biopharma Limited (BNTC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 21.91M |
| Enterprise value | 1.96M |
| Trailing P/E | 51.55 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 96.95 |
| Price/book (mrq) | 1.42 |
| Enterprise value/revenue | 32.05 |
| Enterprise value/EBITDA | -0.09 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | 134.46% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 9.01 |
| 52-week low 3 | 1.86 |
| 50-day moving average 3 | 5.37 |
| 200-day moving average 3 | 3.69 |
Share statistics
| Avg vol (3-month) 3 | 85.75k |
| Avg vol (10-day) 3 | 415.81k |
| Shares outstanding 5 | 2.59M |
| Implied shares outstanding 6 | 8.34M |
| Float 8 | 2.02M |
| % held by insiders 1 | 2.12% |
| % held by institutions 1 | 17.14% |
| Shares short (15 Apr 2024) 4 | 12.22k |
| Short ratio (15 Apr 2024) 4 | 0.67 |
| Short % of float (15 Apr 2024) 4 | 0.63% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.47% |
| Shares short (prior month 15 Mar 2024) 4 | 5.13k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:17 |
| Last split date 3 | 26 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -35,560.66% |
Management effectiveness
| Return on assets (ttm) | -81.53% |
| Return on equity (ttm) | -178.30% |
Income statement
| Revenue (ttm) | 61k |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -21.6M |
| Net income avi to common (ttm) | -21.81M |
| Diluted EPS (ttm) | -236.13 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 20.37M |
| Total cash per share (mrq) | 7.86 |
| Total debt (mrq) | 423k |
| Total debt/equity (mrq) | 2.73% |
| Current ratio (mrq) | 3.62 |
| Book value per share (mrq) | 5.97 |
Cash flow statement
| Operating cash flow (ttm) | -18.07M |
| Levered free cash flow (ttm) | -9.6M |
© 2024 Yahoo. All rights reserved.